All In Biotech

Drug Trial Radar · NCT04479800

Effect of Food on the Pharmacokinetics of ASTX660 in Healthy Volunteers

A Phase 1, Three-Way Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of ASTX660 in Healthy Volunteers

Last checked: Nov 19, 2026Latest source record: Aug 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

21

Actual

Start

Jul 20, 2020

Primary completion

Aug 25, 2020

Study completion Aug 25, 2020

Sponsor

Lead sponsor
Astex Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Jul 21, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a Phase 1, single-dose, open-label, randomized, three-period, three-way crossover study in which healthy adult participants will receive three separate single-dose administrations of ASTX660 capsules under three different conditions.

Conditions

  • Healthy Volunteer

Interventions

  • ASTX660Drug

    Form: capsule; Route of administration: oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetic parameter CmaxTime frame: Predose to 72 hours postdose, up to Day 4
  2. Pharmacokinetic parameter TmaxTime frame: Predose to 72 hours postdose, up to Day 4
  3. Pharmacokinetic parameter λzTime frame: Predose to 72 hours postdose, up to Day 4
  4. Pharmacokinetic parameter t1/2Time frame: Predose to 72 hours postdose, up to Day 4
  5. Pharmacokinetic parameter AUC(0-24h)Time frame: Predose to 24 hours postdose, up to Day 4
  6. Pharmacokinetic parameter AUClastTime frame: Predose to 72 hours postdose, up to Day 4
  7. Pharmacokinetic parameter AUCinfTime frame: Predose to 72 hours postdose, up to Day 4
  8. Pharmacokinetic parameter AUCExtrap (%)Time frame: Predose to 72 hours postdose, up to Day 4
  9. Pharmacokinetic parameter ClastTime frame: Predose to 72 hours postdose, up to Day 4
  10. Pharmacokinetic parameter TlastTime frame: Predose to 72 hours postdose, up to Day 4

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Worldwide Clinical Trials

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.